149 related articles for article (PubMed ID: 2115373)
1. Clinical and laboratory evaluation of the treatment of von Willebrand's disease patients with heat-treated factor VIII concentrate (BPL 8Y).
Pasi KJ; Williams MD; Enayat MS; Hill FG
Br J Haematol; 1990 Jun; 75(2):228-33. PubMed ID: 2115373
[TBL] [Abstract][Full Text] [Related]
2. Clinical and laboratory evaluation of National Health Service factor VIII concentrate (8Y) for the treatment of von Willebrand's disease.
Cumming AM; Fildes S; Cumming IR; Wensley RT; Redding OM; Burn AM
Br J Haematol; 1990 Jun; 75(2):234-9. PubMed ID: 2115374
[TBL] [Abstract][Full Text] [Related]
3. Clinical and biological evaluation in von Willebrand's disease of a von Willebrand factor concentrate with low factor VIII activity.
Goudemand J; Mazurier C; Marey A; Caron C; Coupez B; Mizon P; Goudemand M
Br J Haematol; 1992 Feb; 80(2):214-21. PubMed ID: 1550779
[TBL] [Abstract][Full Text] [Related]
4. Hemostatic effect of a heat-treated factor VIII concentrate (Haemate P) in von Willebrand's disease.
Fukui H; Nishino M; Terada S; Nishikubo T; Yoshioka A; Kinoshita S; Niinomi K; Yoshioka K
Blut; 1988 Apr; 56(4):171-8. PubMed ID: 3128354
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and hemostatic effect of different factor VIII/von Willebrand factor concentrates in von Willebrand's disease type III.
Lethagen S; Berntorp E; Nilsson IM
Ann Hematol; 1992 Dec; 65(6):253-9. PubMed ID: 1457586
[TBL] [Abstract][Full Text] [Related]
6. Heat-treated factor VIII/von Willebrand factor concentrate in platelet-type von Willebrand's disease.
Takahashi H; Tatewaki W; Nagayama R; Hanano M; Tamura M; Yamaguchi T; Takizawa S; Wada K; Shibata A
Haemostasis; 1987; 17(6):353-60. PubMed ID: 3123334
[TBL] [Abstract][Full Text] [Related]
7. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.
Casonato A; Pontara E; Dannhäuser D; Bertomoro A; Sartori MT; Girolami A
Haematologia (Budap); 1994; 26(2):97-109. PubMed ID: 7890268
[TBL] [Abstract][Full Text] [Related]
8. Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease type I.
Lethagen S; Harris AS; Nilsson IM
Blut; 1990 Mar; 60(3):187-91. PubMed ID: 2107887
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo characterization of a high-purity, solvent/detergent-treated factor VIII concentrate: evidence for its therapeutic efficacy in von Willebrand's disease.
Mazurier C; De Romeuf C; Parquet-Gernez A; Goudemand M
Eur J Haematol; 1989 Jul; 43(1):7-14. PubMed ID: 2504619
[TBL] [Abstract][Full Text] [Related]
10. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
Batlle J; López-Fernández MF; Fraga EL; Trillo AR; Pérez-Rodríguez MA
Blood Coagul Fibrinolysis; 2009 Mar; 20(2):89-100. PubMed ID: 19786936
[TBL] [Abstract][Full Text] [Related]
11. DDAVP in type IIa von Willebrand's disease.
Gralnick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
Blood; 1986 Feb; 67(2):465-8. PubMed ID: 3080040
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy and safety of the factor VIII/von Willebrand factor concentrate BIOSTATE in patients with von Willebrand's disease: a prospective multi-centre study.
Dunkley S; Baker RI; Pidcock M; Price J; Seldon M; Smith M; Street A; Maher D; Barrese G; Stone C; Lloyd J
Haemophilia; 2010 Jul; 16(4):615-24. PubMed ID: 20331755
[TBL] [Abstract][Full Text] [Related]
13. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
[TBL] [Abstract][Full Text] [Related]
14. The effects of desmopressin on plasma factor VIII/von Willebrand factor activity in dogs with von Willebrand's disease.
Johnstone IB; Crane S
Can J Vet Res; 1987 Apr; 51(2):189-93. PubMed ID: 3111674
[TBL] [Abstract][Full Text] [Related]
15. Plasma product treatment in various types of von Willebrand's disease.
Berntorp E
Haemostasis; 1994; 24(5):289-97. PubMed ID: 7843640
[TBL] [Abstract][Full Text] [Related]
16. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
[TBL] [Abstract][Full Text] [Related]
17. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
Budde U; Metzner HJ; Müller HG
Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of factor VIII/von Willebrand's factor concentrate (Haemate-P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand disease.
Franchini M; Rossetti G; Tagliaferri A; Pattacini C; Pozzoli D; Lippi G; Manzato F; Bertuzzo D; Gandini G
Haematologica; 2003 Nov; 88(11):1279-83. PubMed ID: 14607757
[TBL] [Abstract][Full Text] [Related]
20. Absence of a bleeding tendency in severe acquired von Willebrand's disease. The role of platelet von Willebrand factor in maintaining normal hemostasis.
Drouin J; Lillicrap DP; Izaguirre CA; Sutherland M; Windsor S; Benford K; Hoogendorn H; Giles AR
Am J Clin Pathol; 1989 Oct; 92(4):471-8. PubMed ID: 2508465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]